EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Comprehensive Assessment of the Multifaceted Impact of Inflammatory Bowel Disease on Quality of Life: Insights From the IBD‐PODCAST Study

F Magro iD, A Dignass iD, F D'Amico iD, F Gomollón iD, P Dinkhauser iD, A Hart, T Karakan iD, I Koutroubakis iD, E V Savarino iD, J Siffledeen iD, L Hammer iD, T Heatta-Speicher und 7 weitere

United European Gastroenterology Journal · 2026-11 · 14 (9)

DOI: 10.1002/ueg2.70327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift United European Gastroenterology Journal, online erschienen am 17.11.2026. Verfasst von F Magro und 18 weiteren Autor:innen. Beteiligte Einrichtung: CINTESIS@RISE Departament, Faculdade de Medicina da Universidade do Porto, Porto, Portugal. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This study was funded by AbbVie..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Inflammatory Bowel Diseases (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), are chronic gastrointestinal disorders, significantly affecting patients' daily lives. The “treat‐to‐target” approach emphasizes the enhancement of patients' quality of life (QoL) as a therapeutic target. This analysis aims to provide an overview of IBD's impact on QoL and further explore the burden related to EIMs, stool urgency, fatigue, and work productivity.

Methods

This analysis was part of the study IBD‐PODCAST descriptive cross‐sectional study including 2185 CD and UC patients from 10 countries. Suboptimal disease control (SDC) based on red flags from STRIDE II recommendations was assessed. The impact of IBD on patients' QoL was assessed, and the relationships of fecal urgency, fatigue, and work productivity to QoL were examined. Comorbidities, extraintestinal manifestations (EIMs), and therapeutic approaches and their effects on QoL were also evaluated.

Results

52.2% of CD patients and 44.3% of UC patients experienced SDC. Impaired QoL was present in 70% of patients with SDC, regardless of advanced treatment use. 41.3% of CD patients and 39.4% of UC patients presented impaired QoL and 30.4% of CD patients and 27.6% of UC patients presented severely impaired QoL. Symptoms and signs of inflammation were more common among those with impaired QoL. Comorbidities (CD; 37.9% and UC; 36.1%) and EIMs (CD; 18.4% and UC; 13.5%) were linked to reduced QoL. Stool urgency was reported by 43.5% of patients, exacerbating QoL concerns. Fatigue and work productivity loss had an important impact on QoL, highlighting the significant burden of IBD.

Conclusion

This study underlined the multifaceted impact of IBD. It emphasizes the need for a holistic disease management approach that prioritizes not only clinical parameters but also patients' QoL, fatigue, stool urgency and work productivity. A multidisciplinary approach is crucial to provide comprehensive care for the chronic effects for patients living with IBD.

Schlagwörter

Stichwörter der Autor:innen

bowel urgencycrohn diseasedisease managementincreased fatigueinflammatory bowel diseasemental healthquality of lifeulcerative colitiswork productivity

Autor:innen und Institutionen

  • CINTESIS@RISE Departament, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
  • Department of Medicine I, Agaplesion Markus Hospital, Goethe University, Frankfurt am Main, Germany.
  • Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Departamento de Medicina, Psiquiatría y Dermatología, Facultad de Medicina, IIS Aragón, CIBEREHD, Universidad de Zaragoza, Zaragoza, Spain.
  • Department of Internal Medicine I, Division of Gastroenterology and Hepatology, Endocrinology and Rheumatology, Klinikum Wels-Grieskirchen, Wels, Austria.
  • Clinical Institute for Inflammation Medicine, Johannes Kepler University, Linz, Austria.

ORCID-Profile: F Magro, A Dignass, F D'Amico, F Gomollón, P Dinkhauser, T Karakan, I Koutroubakis, E V Savarino, J Siffledeen, L Hammer, C Leitner, G Bamias

Förderung

  • This study was funded by AbbVie.

Zitieren

APA

Magro, F., Dignass, A., D'Amico, F., Gomollón, F., Dinkhauser, P., Hart, A., Karakan, T., Koutroubakis, I., Savarino, E. V., Siffledeen, J., Hammer, L., Heatta-Speicher, T., Gemignani, L., Leitner, C., Michelena, N., Prata, R., Tornatore, V., Bamias, G., & IBD PODCAST Investigators (2026). A Comprehensive Assessment of the Multifaceted Impact of Inflammatory Bowel Disease on Quality of Life: Insights From the IBD‐PODCAST Study. United European Gastroenterology Journal, 14(9). https://doi.org/10.1002/ueg2.70327

Vancouver

Magro F, Dignass A, D'Amico F, Gomollón F, Dinkhauser P, Hart A, et al. A Comprehensive Assessment of the Multifaceted Impact of Inflammatory Bowel Disease on Quality of Life: Insights From the IBD‐PODCAST Study. United European Gastroenterology Journal. 2026;14(9). doi:10.1002/ueg2.70327

BibTeX
@article{Magro2026,
  author = {Magro, F and Dignass, A and D'Amico, F and Gomollón, F and Dinkhauser, P and Hart, A and Karakan, T and Koutroubakis, I and Savarino, E V and Siffledeen, J and Hammer, L and Heatta-Speicher, T and Gemignani, L and Leitner, C and Michelena, N and Prata, R and Tornatore, V and Bamias, G and IBD PODCAST Investigators, IBD PODCAST Investigators},
  title = {A Comprehensive Assessment of the Multifaceted Impact of Inflammatory Bowel Disease on Quality of Life: Insights From the IBD‐PODCAST Study},
  journal = {United European Gastroenterology Journal},
  year = {2026},
  volume = {14},
  number = {9},
  doi = {10.1002/ueg2.70327}
}
Kostenlos starten →